| Albin Oh, MD | |
|
11975 Morris Rd Ste 210, Alpharetta, GA 30005-4444 | |
| (707) 709-6922 | |
| (707) 709-6910 |
| Full Name | Albin Oh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 7 Years |
| Location | 11975 Morris Rd Ste 210, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316478332 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 89312 (Georgia) | Primary |
| 207R00000X | Internal Medicine | 271318 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Forsyth | Cumming, GA | Hospital |
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pandya Medical Center Inc | 8022249028 | 8 |
News Archive
The British Psychological Society (BPS) is promoting action to deal with low morale, stress and depression among mental health professionals.
Researchers from the US tested the prophylactic potential of a combination of 2 mAbs administered 3 or 75 days before respiratory challenge in rhesus macaques. They used the rhesus macaque model to test the added benefit of combinatory parenteral administration of 2 high-affinity anti-SARS-CoV-2 mAbs - C144-LS and C135-LS. These mAbs were developed to neutralize the virus and tweaked to improve their pharmacokinetics.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
Calypte Biomedical Corporation, the developer, manufacturer and marketer of the Aware HIV-1/2 OMT (oral fluid) HIV test, announced today that it has been awarded a tax credit of $244,479 under U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Among applicants to U.S. medical schools, those with disabilities who obtained extra test administration time for the Medical College Admission Test in use from 1991 to January 2015 had no significant difference in rate of medical school admission but had lower rates of passing the United States Medical Licensing Examination Step examinations and of medical school graduation, according to a study in the June 9 issue of JAMA, a theme issue on the Americans with Disabilities Act.
› Verified 4 days ago
| Entity Name | Pandya Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730501586 PECOS PAC ID: 8022249028 Enrollment ID: O20140314000813 |
News Archive
The British Psychological Society (BPS) is promoting action to deal with low morale, stress and depression among mental health professionals.
Researchers from the US tested the prophylactic potential of a combination of 2 mAbs administered 3 or 75 days before respiratory challenge in rhesus macaques. They used the rhesus macaque model to test the added benefit of combinatory parenteral administration of 2 high-affinity anti-SARS-CoV-2 mAbs - C144-LS and C135-LS. These mAbs were developed to neutralize the virus and tweaked to improve their pharmacokinetics.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
Calypte Biomedical Corporation, the developer, manufacturer and marketer of the Aware HIV-1/2 OMT (oral fluid) HIV test, announced today that it has been awarded a tax credit of $244,479 under U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Among applicants to U.S. medical schools, those with disabilities who obtained extra test administration time for the Medical College Admission Test in use from 1991 to January 2015 had no significant difference in rate of medical school admission but had lower rates of passing the United States Medical Licensing Examination Step examinations and of medical school graduation, according to a study in the June 9 issue of JAMA, a theme issue on the Americans with Disabilities Act.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Albin Oh, MD 11975 Morris Rd Ste 210, Alpharetta, GA 30005-4444 Ph: (707) 709-6922 | Albin Oh, MD 11975 Morris Rd Ste 210, Alpharetta, GA 30005-4444 Ph: (707) 709-6922 |
News Archive
The British Psychological Society (BPS) is promoting action to deal with low morale, stress and depression among mental health professionals.
Researchers from the US tested the prophylactic potential of a combination of 2 mAbs administered 3 or 75 days before respiratory challenge in rhesus macaques. They used the rhesus macaque model to test the added benefit of combinatory parenteral administration of 2 high-affinity anti-SARS-CoV-2 mAbs - C144-LS and C135-LS. These mAbs were developed to neutralize the virus and tweaked to improve their pharmacokinetics.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
Calypte Biomedical Corporation, the developer, manufacturer and marketer of the Aware HIV-1/2 OMT (oral fluid) HIV test, announced today that it has been awarded a tax credit of $244,479 under U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Among applicants to U.S. medical schools, those with disabilities who obtained extra test administration time for the Medical College Admission Test in use from 1991 to January 2015 had no significant difference in rate of medical school admission but had lower rates of passing the United States Medical Licensing Examination Step examinations and of medical school graduation, according to a study in the June 9 issue of JAMA, a theme issue on the Americans with Disabilities Act.
› Verified 4 days ago
Jeffrey Obiora, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 | |
Dr. Jay Arthur Cherner, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 3330 Preston Ridge Rd, Suite 220, Alpharetta, GA 30005 Phone: 770-410-1600 Fax: 770-410-0006 | |
Randy Turkel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11600 Atlantis Place, Suite B, Alpharetta, GA 30022 Phone: 770-664-4449 Fax: 770-777-6496 | |
Xiaowen Wu, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 10800 Jones Bridge Rd, Ste A, Alpharetta, GA 30022 Phone: 678-867-0135 Fax: 678-867-0137 | |
Dr. Justin Chen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2575 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 800-930-0748 | |
Irfan Ali Syed, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3584 Old Milton Pkwy, Alpharetta, GA 30005 Phone: 678-691-3388 Fax: 678-395-7702 | |
Arezou Fatemi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy, Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 Fax: 678-205-9005 |